- Research Article
- 10.65035/r97yqt05
ROLE OF MICROBIAL INFECTIONS AND BIOCHEMICAL DYSREGULATION IN LEUKEMOGENESIS, DISEASE PROGRESSION, AND DIAGNOSTIC BIOMARKERS: A REVIEW
- Feb 08, 2026
- Journal of Medical & Health Sciences Review
- Asma Tariq + 7 more +7
Uncontrolled hematopoietic cell growth and poor differentiation are hallmarks of leukemia, a diverse group of hematological cancers. A growing body of research indicates that leukemogenesis, illness progression, and clinical outcomes are significantly influenced by microbial infections and metabolic instability. Through processes like immunological dysregulation, genomic instability, chronic inflammation, and direct oncogenic transformation, a number of viruses, bacteria, and parasites have been linked to the development and spread of leukemia. Certain leukemia subtypes are closely linked to viral agents such as hepatitis viruses, Epstein-Barr virus (EBV), and human T-cell leukemia virus type-1 (HTLV-1), while bacterial and parasitic infections may indirectly contribute by causing oxidative stress and prolonged inflammatory reactions. Leukemic cell survival and proliferation are largely dependent on biochemical changes, including aberrant expression of enzymes and cellular metabolites, oxidative stress imbalance, altered cytokine signaling, and metabolic reprogramming. These metabolic alterations offer useful indicators for prognosis and diagnosis in addition to influencing the course of the disease and treatment resistance. Changes in immunological mediators, metabolic intermediates, inflammatory markers, and serum enzymes have demonstrated potential value in risk assessment, early diagnosis, and treatment response monitoring. The current understanding of the involvement of metabolic abnormalities and microbial infections in the development and course of leukemia is compiled in this study. Additionally, it emphasizes the use of new laboratory biomarkers derived from biochemical and viral pathways for diagnosis, prognosis, and individualized illness therapy. The development of more effective leukemia prevention techniques, focused treatments, and sophisticated diagnostic instruments may be aided by an understanding of these interconnected pathways.
Read more